Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy
Sun Pharma will acquire US-based Organon in a $11.75 billion deal, inheriting $8.6 billion debt and strengthening its specialty, biosimilars and women’s health presence in the US market.
Original Source
Read the full article at Livemint →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.